Sibiono Acquisition

Sibiono Acquisition. Means the Company, through its subsidiary Hubei Tongi Benda Ebei Pharmaceutical Co., Ltd, a People's Republic of China entity) ("Tongi Benda") has entered into various share purchase agreements with certain shareholders of Shenzhan Sibiono Gene Tech Co., Ltd, a People's Republic of China company ("Sibiono" and the shareholders referred to as the "Sibiono Shareholders") pursuant to which the Company, through Tongi Benda, would acquire... approximately sixty eight percent (68%), and possibly more, of the outstanding capital stock of Sibiono (the "Sibiono Acquisition"). View More